EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis (Q46634851)

23 December 2017

title

EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis (English)

1 reference

23 December 2017

1 reference

1 reference

23 December 2017

author name string

William D Hardie

1 reference

23 December 2017

Cynthia Davidson

1 reference

23 December 2017

Machiko Ikegami

1 reference

23 December 2017

Timothy D Le Cras

1 reference

23 December 2017

Adrienne Prestridge

1 reference

23 December 2017

Jeffrey A Whitsett

1 reference

23 December 2017

Thomas R Korfhagen

1 reference

23 December 2017

publication date

18 April 2008

1 reference

23 December 2017

American Journal of Physiology - Lung Cellular and Molecular Physiology

published in

1 reference

23 December 2017

volume

294

1 reference

23 December 2017

issue

1 reference

23 December 2017

page(s)

L1217-25

1 reference

23 December 2017

FDA drug approval summary: erlotinib (Tarceva) tablets

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Interstitial lung disease: current concepts of pathogenesis, staging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Improved Movat pentachrome stain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Stat-3 is required for pulmonary homeostasis during hyperoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Acute lung injury as an adverse event of gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Severe acute interstitial pneumonia and gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Defects in pulmonary vasculature and perinatal lung hemorrhage in mice heterozygous null for the Forkhead Box f1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Clinical advances in the diagnosis and therapy of the interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Molecular mechanisms of pulmonary fibrosis and current treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Involvement of the epidermal growth factor receptor in epithelial repair in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Midkine is regulated by hypoxia and causes pulmonary vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Erlotinib in previously treated non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Relationship of epidermal growth factor receptors to goblet cell production in human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Interstitial lung disease following erlotinib (Tarceva) in a patient who previously tolerated gefitinib (Iressa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Conditional expression of fibroblast growth factor-7 in the developing and mature lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Basal-like cells constitute the proliferating cell population in cystic fibrosis airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Transforming growth factor alpha (TGF(alpha)) is increased during hyperoxia and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00020.2008

10.1152/AJPLUNG.00020.2008

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017